amphotericin-b and Leukemia--Hairy-Cell
amphotericin-b has been researched along with Leukemia--Hairy-Cell* in 7 studies
Reviews
1 review(s) available for amphotericin-b and Leukemia--Hairy-Cell
Article | Year |
---|---|
Mycotic pulmonary artery aneurysm due to Aspergillus infection in a patient with leukemia: case report and review of the literature.
We present a case of a patient with hairy cell leukemia and pulmonary aspergillosis who developed a cycotic pulmonary artery aneurysm despite prolonged antifungal therapy. A review of the literature in regards to incidence, etiology, clinical manifestations and treatment options is included. Topics: Abscess; Acyclovir; Amphotericin B; Aneurysm, Infected; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Aspergillus; Caspofungin; Ceftazidime; Clindamycin; Echinocandins; Fluconazole; Humans; Leukemia, Hairy Cell; Lipopeptides; Male; Middle Aged; Mouth; Ofloxacin; Pneumonia; Pulmonary Artery; Pulmonary Aspergillosis; Valacyclovir; Valine; Vancomycin | 2010 |
Other Studies
6 other study(ies) available for amphotericin-b and Leukemia--Hairy-Cell
Article | Year |
---|---|
Disseminated sporotrichosis in a patient with hairy cell leukemia treated with amphotericin B and posaconazole.
We describe a case of disseminated Sporothrix schenckii infection in a man with underlying hairy cell leukemia. The immunological defects associated with this malignancy, as well as the management of refractory sporotrichosis are reviewed. Topics: Adult; Amphotericin B; Antifungal Agents; Humans; Leg; Leukemia, Hairy Cell; Male; Skin; Sporothrix; Sporotrichosis; Triazoles | 2012 |
Multiple opportunistic infections after high-dose steroid therapy for giant cell arteritis in a patient previously treated with a purine analog.
We present the case of a 74-y-old HIV-negative female who suffered simultaneously from multiple opportunistic infections and a Klebsiella pneumoniae sepsis during high-dose steroids for giant cell arteritis. The patient was treated with a purine analog due to hairy cell leukaemia 10 y previously. Purine analog therapy can lead to long lasting defects in cell-mediated immunity. In these patients, treatment with steroids should be closely monitored with CD4 counts. Topics: Aged; Amphotericin B; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Agents; Aspergillosis; Cladribine; Cytomegalovirus; Dexamethasone; Esophagitis; Female; Giant Cell Arteritis; Herpes Simplex; Humans; Klebsiella Infections; Klebsiella pneumoniae; Leukemia, Hairy Cell; Methylprednisolone; Opportunistic Infections; Pneumocystis carinii; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Hairy cell leukemia with concurrent cryptococcus infection.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cladribine; Cryptococcosis; Fluconazole; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Remission Induction | 2003 |
Disseminated zygomycosis: a rare cause of infection in patients with hematologic malignancies.
Topics: Amphotericin B; Antineoplastic Agents; Cladribine; Deoxycholic Acid; Drug Combinations; Fatal Outcome; Humans; Leukemia, Hairy Cell; Male; Middle Aged; Neutropenia; Zygomycosis | 2003 |
Hairy cell leukemia and mucormycosis. Treatment with alpha-2 interferon.
Right maxillary sinus mucormycosis developed in a 45-year-old patient with hairy cell leukemia and pancytopenia. The patient recovered with surgical debridement, amphotericin therapy, and institution of alpha-2 interferon as therapy for his hairy cell leukemia. This may be the first case of the use of alpha-2-interferon therapy in a patient with documented systemic fungal infection and hairy cell leukemia and a rare example of recovery from this infection in a hematologic malignancy. Topics: Amphotericin B; Combined Modality Therapy; Debridement; Humans; Interferon Type I; Leukemia, Hairy Cell; Male; Maxillary Sinus; Middle Aged; Mucormycosis; Pancytopenia; Sinusitis | 1986 |
Candida rugosa in immunocompromised infection. Case reports, drug susceptibility, and review of the literature.
Candida rugosa was isolated from two patients. One patient had acute leukemia and developed invasive disease due to this yeast on two occasions while granulocytopenic. Her infection was eventually cured after treatment with amphotericin B. In another immunocompromised patient, the yeast was isolated from the sputum in the presence of a pulmonary infiltrate, but there was no other evidence for a pathogenic role. Antifungal susceptibility testing of the first patient's isolate and three environmental isolates showed all four to be susceptible to amphotericin B, miconazole, and flucytosine, and only the patient isolate was resistant to ketoconazole. These results suggest possibilities for therapy in future encounters. It appears that C. rugosa, a common pathogen in cattle, can be pathogenic in humans under the appropriate circumstances. Topics: Aged; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Candida; Candidiasis; Female; Humans; Immune Tolerance; Leukemia, Hairy Cell; Leukemia, Myeloid; Male; Microbial Sensitivity Tests; Middle Aged; Recurrence; Sputum | 1985 |